UNIV NEBRASKA has a total of 1,459 patent applications. It decreased the IP activity by 7.0%. Its first patent ever was published in 1970. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are CHARLOTTE MECKLENBURG HOSPITAL, UNIV VIRGINIA PATENT FOUNDATION and MAYO FOUND MEDICAL EDUCATION & RES.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 599 | |
#2 | WIPO (World Intellectual Property Organization) | 304 | |
#3 | EPO (European Patent Office) | 163 | |
#4 | Australia | 157 | |
#5 | Canada | 116 | |
#6 | China | 36 | |
#7 | Japan | 16 | |
#8 | Brazil | 12 | |
#9 | Israel | 6 | |
#10 | Mexico | 6 | |
#11 | Ireland | 5 | |
#12 | Republic of Korea | 5 | |
#13 | New Zealand | 5 | |
#14 | Norway | 4 | |
#15 | South Africa | 4 | |
#16 | Finland | 3 | |
#17 | Argentina | 2 | |
#18 | Denmark | 2 | |
#19 | Spain | 2 | |
#20 | Hungary | 2 | |
#21 | India | 2 | |
#22 | Belgium | 1 | |
#23 | Germany | 1 | |
#24 | Hong Kong | 1 | |
#25 | Philippines | 1 | |
#26 | Poland | 1 | |
#27 | Russian Federation | 1 | |
#28 | Sweden | 1 | |
#29 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Machines | |
#6 | Organic fine chemistry | |
#7 | Packaging and shipping |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Diagnosis and surgery | |
#4 | Microorganisms | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Unspecified technologies | |
#8 | Heterocyclic compounds | |
#9 | Measuring microorganism processes | |
#10 | Manipulators |
# | Name | Total Patents |
---|---|---|
#1 | Farritor Shane | 115 |
#2 | Oleynikov Dmitry | 42 |
#3 | Iversen Patrick L | 41 |
#4 | Rentschler Mark | 40 |
#5 | Gendelman Howard E | 39 |
#6 | Porter Thomas R | 38 |
#7 | Lehman Amy | 37 |
#8 | Mcdonald Thomas L | 35 |
#9 | Liu Xin-Ming | 34 |
#10 | Wang Dong | 33 |
Publication | Filing date | Title |
---|---|---|
WO2021035114A1 | Prodrugs and formulations thereof | |
WO2021007344A1 | Drug delivery using microneedle arrays | |
WO2021007168A1 | Dissolvable and degradable artificial circulation systems for large volume tissues | |
US2020410669A1 | Animal Detection Based on Detection and Association of Parts | |
WO2020211859A1 | Hydrogel drug delivery composition | |
WO2020181205A1 | Antimicrobial scaffolds | |
WO2020160418A1 | Virus-like particles and methods of use thereof | |
WO2020159946A1 | Electrospun nanofiber-based dressings and methods of manufacture and use thereof | |
WO2020124072A1 | Nanofiber structures and methods of manufacture and use thereof | |
WO2020112931A1 | Antiviral prodrugs and nanoformulations thereof | |
WO2020102520A1 | Tactile stimulation device | |
WO2020097442A2 | Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases | |
WO2020087057A1 | Macromolecular prodrug-based thermosensitive injectable gel as a novel drug delivery platform | |
WO2020086555A1 | Antiviral prodrugs and nanoformulations thereof | |
WO2020081914A1 | Upper limb prostheses | |
US2020148568A1 | Integrated Unicellular/Filamentous Algal Production, Harvesting and Remediation System | |
WO2020077174A1 | Phosphodiesterase inhibitors | |
WO2020072717A1 | Bypass graft | |
US2020110009A1 | Devices and Methods for Eluting and Concentrating Large DNA Molecules | |
US2020099379A1 | Circuits based on magnetoelectric transistor devices |